Mr. Miguel Martin reports

AURORA CANNABIS TO HOST FIRST QUARTER 2027 INVESTOR CONFERENCE CALL

Aurora Cannabis Inc. will host an investor conference call on Wednesday, Aug. 5, 2026, at 8 a.m. Eastern Time or 6 a.m. Mountain Time, to discuss its financial results for the first quarter 2027. The company will report its financial results prior to market open that same morning.

Investor conference call details

Date:  Wednesday, Aug. 5, 2026

Time:  8 a.m. Eastern Time or 6 a.m. Mountain Time

A webcast will be available.

Miguel Martin, executive chairman and chief executive officer, and Simona King, chief financial officer, will host the call and question-and-answer period. This weblink has also been posted to the company's investor info link at the company's website under events.

About Aurora Cannabis Inc.

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance and a deep commitment to patient care. Aurora serves both medical and consumer markets across Canada, Europe, Australia and New Zealand, with a strategic focus on high-margin opportunities and a medical-first approach. Aurora's portfolio of trusted, leading brands includes Aurora, MedReleaf, Pedanios, IndiMed, San Raf, Tasty's and Whistler Medical Marijuana Co. With world-class good-manufacturing-practice-certified manufacturing facilities in Canada and Germany and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of opening the world to cannabis.

Aurora's common shares trade on Nasdaq and the Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.